DIFFERIN (nda020338)- (0.1%)

Generic Name	ADAPALENE	Innovator	GALDERMA LABS LP
Dosage	0.1%
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	2010-May-31	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	DIFFERIN® Solution is indicated for the topical treatment of acne vulgaris.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
2	0	2

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
0.1%	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	0

Manufacturing Details of DIFFERIN